Not logged in Share Save
Share Save
Share Save
Share Save
Changing Gadolinium-Based Contrast Agents to Prevent Recurrent Acute Adverse Drug Reactions: 6-Year Cohort Study Using Propensity Score Matching (Vol 25, pg 824, 2024) Han, Min Woo; Suh, Chong Hyun; Kim, Pyeong Hwa; Kim, Seonok; Kim, Ah Young; Do, Kyung-Hyun; Lee, Jeong Hyun; Gwon, Dong-Il; Jung, Ah Young; Lee, Choong Wook Share Save
Share Save
Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules: 10-Year Experience Park, Sang Ik; Baek, Jung Hwan; Lee, Da Hyun; Chung, Sae Rom; Song, Dong Eun; Kim, Won Gu; Kim, Tae Yong; Sung, Tae-Yon; Chung, Ki-Wook; Lee, Jeong Hyun Share Save
Share Save
Ethanol Ablation of Ranulas and Risk Factor Analysis for Recurrence Suh, Pae Sun; Lee, Jeong Hyun; Roh, Yun Hwa; Moon, Hye Hyun; Chung, Sae Rom; Kwon, Min Su; Choi, Young Jun; Lee, Yoon Se; Baek, Jung Hwan; Choi, Seung-Ho Share Save
Share Save
Final analysis of the prospective, randomized phase II STAMP trial: Adjuvant gemcitabine plus cisplatin (GemCis) versus capecitabine (CAP) in node-positive extrahepatic cholangiocarcinoma (CCA) Jeong, H.; Kim, K-P.; Jeong, J. H.; Hwang, D. W.; Lee, J. H.; Kim, K-H.; Moon, D-B.; Lee, M. A.; Park, S. J.; Chon, H.; Park, J-H.; Lee, J. S.; Ryoo, B-Y.; Yoo, C. Share Save
Neoadjuvant durvalumab plus gemcitabine and cisplatin (D plus GemCis) versus gemcis alone for localized biliary tract cancer (BTC): Results of a randomized, multicenter, open-label, phase II trial (DEBATE) Yoo, C.; Park, J. O.; Kim, K-P.; Hyung, J.; Ryoo, B-Y.; Hong, J. Y.; Shin, S. H.; Song, T. J.; Oh, D.; Lee, W.; Kwak, B. J.; Lee, J. H.; Hwang, D. W. Share Save
Share Save
Share Save
Diagnostic Performance of Five Adult-based US Risk Stratification Systems in Pediatric Thyroid Nodules Kim, Pyeong Hwa; Yoon, Hee Mang; Baek, Jung Hwan; Chung, Sae Rom; Choi, Young Jun; Lee, Jeong Hyun; Lee, Jin Seong; Jung, Ah Young; Cho, Young Ah; Bak, Boram; Na, Dong Gyu Share Save
Share Save
Share Save
Share Save
Share Save
Share Save